July 6, 2012 — Vascular Closure Systems Inc. announced that the 30-day follow-up results for the Phase I first-in-human (FIH) clinicals have been confirmed by Doppler and ultrasound evaluation. The evaluation confirmed normal vessel healing, with complete absorption of the FastSeal sealing element.

July 5, 2012 — Avinger Inc., a medical device manufacturer of multifunctional catheters, announced in June that it has successfully completed enrollment in its CONNECT II global clinical trial.

July 3, 2012 — The Supreme Court ruling upholding the Affordable Care Act gives extra punch to the market forces pushing healthcare away from fee-for-service and re-injects a new sense of urgency into the transformation of the health industry, according to a report published today by the Health Research Institute (HRI) of PwC US.

July 3, 2012 — Flexible Stenting Solutions Inc., a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced that it has extended its CE mark authorized family of peripheral vascular stents to include the FlexStent iliac self expanding stent system.

July 3, 2012 — While rare, when sudden cardiac death occurs in a seemingly healthy competitive young athlete, the societal loss is high. At a time when the world is battling obesity in epidemic proportions, fear should not affect how parents view athletic participation.

July 3, 2012 — Despite the rising incidence of peripheral arterial disease (PAD), there has been little data available on the prevalence and clinical correlates of sub-clinical atherosclerosis in the peripheral arteries in large population-based samples.

July 2, 2012 — A study led by primary investigator Dr. Vitharani Kunanithy of Kingston General Hospital, Kingston, Ontario, Canada, may provide hope for heart failure patients undergoing cardiac resychronization therapy.